article thumbnail

9th Advanced GMP Workshop 2024 was organised by IPA

Express Pharma

It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalisation, and fostering a quality-first mindset.”

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. On the pricing of generics, IPA stated, While generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sustainability crucial for pharma’s supply chain future

European Pharmaceutical Review

Implementing ESG measures “The rate of change is increasing rapidly and we expect this to be one of the biggest themes for manufacturing in 2024,” stated Silvia Forroova, Director of Partnerships & Sustainability at Informa Markets.

article thumbnail

What Is Driving CPOs Today? Focus Shifts to Technology and Processes

Pharma and Life Sciences Blog

Focus Shifts to Technology and Processes annmarie@AZglo… Fri, 01/19/2024 - 22:57 Almost half (46%) of enterprises report that their CPO now plays a bigger role in high-level decision-making. That was just one of the results of the GEP-sponsored 2024 Annual ProcureCon CPO Report. What Is Driving CPOs Today?

article thumbnail

The next industrial revolution in India will be driven by biotechnology

Express Pharma

He addressed the CII 6th Pharma and Life Sciences Summit 2024 in New Delhi. He praised the reforms undertaken by the Government in the last decade, which have helped the industry thrive, particularly through structural and process improvements.

Vaccines 105